Trualt Bioenergy Resolves SEBI Non-Compliance Issues

Trualt Bioenergy Ltd has confirmed the resolution of non-compliance notices issued by the BSE and NSE regarding SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company has paid all fines imposed by the stock exchanges and updated its board composition to satisfy regulatory mandates.

Reader Takeaway: Appointment of Independent Woman Director restores board compliance, following settlement of procedural non-compliance fines.

What just happened

Following notices from the BSE and NSE dated August 14, 2026, and August 25, 2026, the Board of Directors of Trualt Bioenergy reviewed identified lapses on September 22, 2026. The company faced scrutiny over board composition and procedural failures in providing prior notice for board meetings.

Key Actions

The board has appointed Dr. Sarvamangala R. Patil as an Additional Director (Non-Executive Independent Woman Director) effective September 22, 2026. This appointment addresses the requirement under Regulation 17(1) for a woman independent director. Additionally, the company acknowledged that its failure to provide prior intimation for board meetings under Regulation 29 was an inadvertent procedural error.

Financial and Governance Impact

Trualt Bioenergy has confirmed the full payment of fines levied by the exchanges. The board has instructed management to implement more rigorous oversight to ensure future compliance with all listing obligations. The company states it remains committed to maintaining high governance standards.